Logo image of DOS.CA

DIOS EXPLORATION INC (DOS.CA) Stock Fundamental Analysis

TSX-V:DOS - CA25455U1003 - Common Stock

0.025 CAD
0 (0%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

2

Overall DOS gets a fundamental rating of 2 out of 10. We evaluated DOS against 803 industry peers in the Metals & Mining industry. While DOS seems to be doing ok healthwise, there are quite some concerns on its profitability. DOS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

DOS had negative earnings in the past year.
In the past year DOS has reported a negative cash flow from operations.
DOS.CA Yearly Net Income VS EBIT VS OCF VS FCFDOS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2023 2024 -1M -2M -3M -4M

1.2 Ratios

With a Return On Assets value of -119.18%, DOS is not doing good in the industry: 76.71% of the companies in the same industry are doing better.
The Return On Equity of DOS (-124.07%) is worse than 67.87% of its industry peers.
Industry RankSector Rank
ROA -119.18%
ROE -124.07%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DOS.CA Yearly ROA, ROE, ROICDOS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

DOS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DOS.CA Yearly Profit, Operating, Gross MarginsDOS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2023 2024

6

2. Health

2.1 Basic Checks

DOS has about the same amout of shares outstanding than it did 1 year ago.
DOS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DOS.CA Yearly Shares OutstandingDOS.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2023 2024 20M 40M 60M 80M 100M
DOS.CA Yearly Total Debt VS Total AssetsDOS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2023 2024 2M 4M 6M

2.2 Solvency

DOS has an Altman-Z score of 3.27. This indicates that DOS is financially healthy and has little risk of bankruptcy at the moment.
DOS has a Altman-Z score of 3.27. This is comparable to the rest of the industry: DOS outperforms 57.16% of its industry peers.
DOS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.27
ROIC/WACCN/A
WACCN/A
DOS.CA Yearly LT Debt VS Equity VS FCFDOS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2023 2024 0 2M 4M 6M

2.3 Liquidity

DOS has a Current Ratio of 1.03. This is a normal value and indicates that DOS is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.03, DOS perfoms like the industry average, outperforming 42.71% of the companies in the same industry.
A Quick Ratio of 1.03 indicates that DOS should not have too much problems paying its short term obligations.
DOS's Quick ratio of 1.03 is in line compared to the rest of the industry. DOS outperforms 45.45% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 1.03
DOS.CA Yearly Current Assets VS Current LiabilitesDOS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2023 2024 200K 400K 600K 800K 1M

0

3. Growth

3.1 Past

DOS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1466.67%.
EPS 1Y (TTM)-1466.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DOS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DOS.CA Price Earnings VS Forward Price EarningsDOS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DOS.CA Per share dataDOS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01 0.02 -0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

DOS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DIOS EXPLORATION INC

TSX-V:DOS (9/5/2025, 7:00:00 PM)

0.025

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-23 2025-07-23
Earnings (Next)11-03 2025-11-03
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners20.03%
Ins Owner ChangeN/A
Market Cap3.04M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.94
P/tB 0.94
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -119.18%
ROE -124.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 1.03
Altman-Z 3.27
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1466.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y73.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y54.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-59.6%
OCF growth 3YN/A
OCF growth 5YN/A